Throughout 2016 Optum is offering a comprehensive continuing education program in which its experts share actionable insight on workers’ compensation trends and challenges. Following each presentation, they will provide Key Takeaways reiterating guidance, that when applied, lead to better outcomes.
- Opioid analgesics have an important place in medication therapy for the treatment of pain. However, careful consideration of the risks and benefits associated with their use must occur, because opioid analgesics can have an adverse effect on the body.
- With collaboration and a goal-oriented treatment plan, the use of opioid analgesics and other medications can be effectively managed.
- Abuse-deterrent opioid formulations do not guarantee protection from overdose.
- Rheumatoid arthritis is a chronic inflammatory disease not typically caused by a workplace injury.
- A claimant-specific plan of care should detail the goals and expectations of treatment.
- Consider the type and location of a fracture before the placement of a bone growth stimulator.
- The identified debtor has 30 days to accept or dispute the payment request from CMS.
Click to download Optum’s latest resource (PDF) featuring a compilation of these and other key takeaways shared during the first six months of our 2016 Continuing Education Program.
This is a sponsored post from WorkCompWire marketing partner Optum.